HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Markus Mitterhauser Selected Research

Carbohydrates

6/2020Sorbitol as a Polar Pharmacological Modifier to Enhance the Hydrophilicity of 99mTc-Tricarbonyl-Based Radiopharmaceuticals.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Markus Mitterhauser Research Topics

Disease

32Neoplasms (Cancer)
01/2023 - 03/2005
20Prostatic Neoplasms (Prostate Cancer)
11/2023 - 06/2006
7Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 02/2013
7Inflammation (Inflammations)
11/2021 - 01/2008
7Neoplasm Metastasis (Metastasis)
01/2021 - 08/2006
7Mood Disorders (Mood Disorder)
01/2019 - 01/2008
4Glioma (Gliomas)
01/2023 - 01/2018
4Alzheimer Disease (Alzheimer's Disease)
01/2022 - 11/2012
4Obesity
01/2019 - 10/2012
4Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2017 - 12/2014
4Anxiety Disorders (Anxiety Disorder)
10/2015 - 10/2010
3Epilepsy (Aura)
11/2022 - 10/2014
3Atherosclerosis
11/2021 - 01/2017
3Breast Neoplasms (Breast Cancer)
01/2019 - 11/2003
3Major Depressive Disorder (Major Depressive Disorders)
01/2018 - 11/2012
3Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2018 - 01/2016
2Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 03/2006
2Lymphoma (Lymphomas)
11/2021 - 01/2019
2Treatment-Resistant Depressive Disorder
09/2020 - 05/2019
2Type 2 Diabetes Mellitus (MODY)
01/2020 - 01/2020
2Arthritis (Polyarthritis)
01/2019 - 05/2015
2Atherosclerotic Plaque (Atheroma)
01/2018 - 07/2016
2Asthma (Bronchial Asthma)
05/2015 - 04/2015
2Glaucoma
05/2015 - 04/2015
2Temporal Lobe Epilepsy
10/2014 - 11/2010
2Portal Hypertension
06/2014 - 04/2013
2Social Phobia
10/2010 - 05/2007
2Infections
02/2005 - 10/2004
1Bile Duct Neoplasms (Bile Duct Cancer)
11/2023
1Carcinogenesis
01/2023
1Lymphatic Metastasis
11/2022
1Residual Neoplasm
06/2022
1Myocardial Infarction
01/2022
1Ischemia
01/2022
1Cardiac Sudden Death (Sudden Cardiac Arrest)
01/2022
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2022
1Arteritis
11/2021
1Anemia
05/2021
1Thrombocytopenia (Thrombopenia)
05/2021

Drug/Important Bio-Agent (IBA)

9Biomarkers (Surrogate Marker)IBA
01/2023 - 06/2014
85-HT1A Serotonin ReceptorIBA
01/2019 - 05/2007
7Proteins (Proteins, Gene)FDA Link
01/2023 - 08/2013
7LigandsIBA
11/2022 - 12/2018
5Amino AcidsFDA Link
01/2023 - 03/2005
5Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
11/2021 - 01/2016
5Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA
03/2016 - 02/2013
4Methionine (L-Methionine)FDA Link
01/2023 - 03/2005
4AntigensIBA
01/2023 - 06/2021
4Monoamine Oxidase (MAO)IBA
09/2020 - 09/2014
4melanin-concentrating hormone receptorIBA
01/2019 - 10/2012
4Acetates (Acetic Acid Esters)FDA Link
11/2018 - 11/2015
3RadiopharmaceuticalsIBA
11/2023 - 03/2005
3Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2023 - 01/2018
368Ga-pentixaforIBA
11/2022 - 01/2018
3Antidepressive Agents (Antidepressants)IBA
01/2022 - 11/2014
3177Lu-PSMA-617IBA
01/2021 - 05/2019
3Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2019 - 08/2013
3fluoromisonidazoleIBA
01/2018 - 01/2016
2Radioisotopes (Radionuclides)IBA
11/2023 - 01/2018
2ParaffinIBA
11/2022 - 06/2021
2Dopamine (Intropin)FDA LinkGeneric
01/2020 - 11/2014
2Glucose (Dextrose)FDA LinkGeneric
01/2020 - 01/2020
2FluoridesIBA
04/2019 - 01/2019
2Chemokine ReceptorsIBA
01/2019 - 01/2018
2Fatty Acid Synthases (Fatty Acid Synthase)IBA
11/2018 - 11/2015
2Radium-223IBA
01/2018 - 09/2016
2Prostate-Specific Antigen (Semenogelase)IBA
12/2015 - 06/2006
2Neurotransmitter Agents (Neurotransmitter)IBA
08/2014 - 07/2014
2Serotonin (5 Hydroxytryptamine)IBA
07/2014 - 11/2010
2N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA
11/2010 - 10/2010
2Ciprofloxacin (Cipro)FDA LinkGeneric
02/2005 - 10/2004
1PSMA I&TIBA
11/2023
1KP 1339IBA
11/2023
1RutheniumIBA
11/2023
1Hormones (Hormone)IBA
01/2023
1Antigen Receptors (Antigen Receptor)IBA
01/2023
1GalliumIBA
06/2022
1KetamineFDA LinkGeneric
01/2022
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2022
1Immune Checkpoint InhibitorsIBA
11/2021
1Phosphates (Orthophosphate)IBA
09/2021
1Hemoglobins (Hemoglobin)IBA
05/2021
1Docetaxel (Taxotere)FDA Link
01/2021
1cabazitaxelFDA Link
01/2021
1PSMA-617IBA
01/2021
1AndrogensIBA
01/2021
1enzalutamideIBA
01/2021
1Crystallins (Crystallin)IBA
01/2021
1abirateroneIBA
01/2021
1Androgen Receptors (Androgen Receptor)IBA
01/2021

Therapy/Procedure

30Therapeutics
11/2023 - 11/2003
11Castration
11/2023 - 01/2018
4Radiotherapy
01/2023 - 01/2016
3Prostatectomy (Retropubic Prostatectomy)
09/2023 - 12/2015
2Pancreaticoduodenectomy
09/2020 - 03/2017
1Cytoreduction Surgical Procedures
06/2022
1Ligation
01/2022
1Denervation
01/2022
1Immunotherapy
11/2021
1Intravenous Administration
01/2021